Evidence map›Paper›PMID 41957506›Full record

ArticleScientific reports2026

Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer.

Parinishtha Bhalla, David Dueñas Gaviria, Patrick Kupczyk, Ali Seif Amir Hosseini, Lena Conradi, Uli Fehrenbach, Matthaeus Felsenstein, Dou Ma, Alexander Semaan, Shadi Albarqouni

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Parinishtha Bhalla *Clinic for Diagnostic and Interventional Radiology, University Hospital Bonn, University of Bonn, Bonn, Germany.
David Dueñas Gaviria *Clinic for Diagnostic and Interventional Radiology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Patrick KupczykClinic for Diagnostic and Interventional Radiology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Ali Seif Amir HosseiniDepartment of Clinical and Intervention Radiology, University Medical Center Göttingen, Göttingen, Germany.
Lena ConradiDepartment of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
Uli FehrenbachDepartment of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Matthaeus FelsensteinDepartment of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Dou MaDepartment of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Alexander Semaan *Clinic and Polyclinic for General, Visceral, Thoracic, and Vascular Surgery, University of Bonn, Bonn, Germany.
Shadi Albarqouni *Clinic for Diagnostic and Interventional Radiology, University Hospital Bonn, University of Bonn, Bonn, Germany. shadi.albarqouni@ukbonn.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with prognosis strongly influenced by the presence of lymph node metastasis (LNM). However, preoperative LNM assessment from computed tomography (CT) is limited by low sensitivity, high inter-observer variability, and substantial heterogeneity across imaging protocols. This retrospective multi-center study (546 patients from three institutions) introduces a privacy-preserving deep learning framework that integrates large-scale CT foundation model pre-training with heterogeneity-aware federated optimization to improve LNM detection in PDAC. A CT Vision Foundation Model, pre-trained on 148,000 volumetric CT scans using contrastive self-supervised learning, is fine-tuned to generate transferable 3D representations for patient-level LNM classification. To enable decentralized model training while mitigating inter-institutional variability, we extend federated aggregation to jointly account for label-distribution discrepancies and representation-level divergence across clients. The centralized model achieved a balanced accuracy of 0.601 and a diagnostic odds ratio (DOR) of 3.45, outperforming classical machine learning baselines and prior PDAC LNM approaches. Under federated settings, the proposed heterogeneity-aware strategy consistently outperformed standard FedAvg, recovering a substantial proportion of the centralized model's performance while preserving strict data privacy. In particular, it improved balanced accuracy by 12.6% over FedAvg and demonstrated superior discriminative ability across all participating cohorts. These findings indicate that combining foundation model pre-training with discrepancy-aware federated learning enhances generalization, robustness, and clinical relevance for multi-center PDAC LNM detection. The proposed framework offers a scalable and privacy-preserving pathway for deploying deep learning models across distributed healthcare systems.

Indexed as

Carcinoma, Pancreatic DuctalLymphatic MetastasisPancreatic NeoplasmsTomography, X-Ray ComputedDeep LearningFederated LearningFemaleHumansLymph NodesMaleRetrospective StudiesFederated LearningFoundation ModelsPancreatic ductal adenocarcinoma

Identifiers

PMID41957506
PMCPMC13068997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.